Skip to Content
Home | news | Health Care

Health Care

Pulling Back the Curtain: Carter unveils report on lowering prescription drug prices

| Posted in Press Releases

SAVANNAH, GA – Rep. Earl L. "Buddy" Carter (R-GA) today announced the “Pulling Back the Curtains on PBMs” report, an initiative to educate Members of Congress and the public on the role pharmacy benefit managers (PBMs), the pharmaceutical industry’s middlemen, play in driving up costs for medications, delaying necessary treatments for patients, and robbing hope from their loved…

Carter sounds alarm on conflict of interest threatening veterans’ access to prescription medications

| Posted in Press Releases

WASHINGTON, D.C. — Congressman Buddy Carter (R-GA) and Senator Tom Cotton (R-Arkansas) sent a letter today to Seileen Mullen, the Acting Assistant Secretary of Defense for Health Affairs, seeking answers about the recent announcement that a pharmacy benefit manager (PBM), Express Scripts, will strip pharmaceutical access away from TRICARE patients and their families, a move that…

Carter, Ross introduce Improving Access to Safe Medicines Act

| Posted in Press Releases

WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA) and Deborah Ross (D-NC) introduced bipartisan legislation today that will increase patients’ access to pharmaceuticals by cutting unnecessary bureaucracy within the Drug Enforcement Agency (DEA). The Improving Access to Safe Medicines Act will ensure that the DEA makes timely decisions on whether to de-schedule drugs recommended…

Carter introduces bipartisan Access to Critical Non-Emergency Medical Transportation Services Act

| Posted in Press Releases

WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA), Tony Cárdenas (D-CA) and Sanford D. Bishop, Jr. (D-GA) today introduced The Access to Critical Non-Emergency Transportation Services Act, which expands access to non-emergency medical transportation (NEMT) for vulnerable dual-eligible Medicare and Medicaid patients. Currently, Medicare beneficiaries must obtain prior…

Carter launches bipartisan caucus to secure America's pharmaceutical independence

| Posted in Press Releases

WASHINGTON, D.C. —  Rep. Earl L. "Buddy" Carter (GA-01) formed the bipartisan Congressional Domestic Pharmaceutical Manufacturing Caucus, a new working group in Congress that will focus on re-shoring and protecting the U.S.’s pharmaceutical manufacturing base.  The Caucus plans to help advance legislation that incentivizes more domestic production for critical…

Carter-backed effort to expand hearing aid access finalized by FDA

| Posted in Press Releases

WASHINGTON, D.C. – The Food and Drug Administration (FDA) finalized a rule today that will increase access to hearing aids by making them available over-the-counter, an issue Rep. Earl L. “Buddy” Carter (R-GA) has been championing since 2017: “Hearing aids should be just as accessible as reading glasses,” said Carter. “Only 1 in 5 Americans who need a hearing aid use one, mainly due to…

Carter increases access to telehealth services

| Posted in Press Releases

WASHINGTON, D.C. – The House today passed H.R. 4040, the Advancing Telehealth Beyond COVID-19 Act, which included provisions from Rep. Earl L. “Buddy” Carter’s (R-GA) Greater Access to Telehealth Act that will expand access to telehealth services. “As a pharmacist who grew up in South Georgia, I know first-hand how difficult access to health care can be for rural Americans,”…

Carter sounds alarm on Biden Admin’s pro-abortion threats against pharmacists: “disastrous consequences”

| Posted in Press Releases

WASHINGTON, D.C. – Following last week’s Department of Health and Human Services (HHS) guidance warning pharmacists that they may be in violation of civil rights laws if they do no fill prescriptions for elective abortions, Rep. Earl L. “Buddy” Carter (R-GA), a pharmacist by trade, sent a letter highlighting the widespread legal and ethical consequences of the irresponsible guidance.…

Carter: "Help is on the way" for Lymphedema patients

| Posted in Press Releases

WASHINGTON, D.C. – The Energy and Commerce Committee today passed the bipartisan Lymphedema Treatment Act, which expands Medicare coverage to include necessary compression treatment items for Lymphedema. Nearly 5 million people suffer from this disease nationwide, which is frequently the result of cancer treatments and causes life-long, painful swelling that can impede daily…

Carter on FDA expanding access to COVID-19 antiviral medication

| Posted in Press Releases

WASHINGTON, D.C. – The U.S. Food and Drug Administration (FDA) will now allow authorized, state-licensed pharmacists to prescribe Paxlovid, an oral treatment for COVID-19.  Rep. Earl L. “Buddy” Carter (R-GA), a pharmacist by trade, sees this Emergency Use Authorization expansion as the necessary link between COVID-19 patients and treatment:  “Pharmacists are the…